<i>Breakfast with Benjamin</i>: The biotech stock bloodbath is starting to look like more than just political bluster.
Recent fund performance is leaving higher-profile competitors in the dust.
Stock market volatility drives up the appetite for alternative strategies.
<i>Breakfast with Benjamin</i>: If you can believe it, Janet Yellen is still teasing the markets with the idea of rate hike this year.
<i>Breakfast with Benjamin</i>: A flat return for cash is turning out to be the best bet out there, which should send a message to the Fed and the markets.
<i>Breakfast with Benjamin</i>: If you thought 2014 was a rough year for mutual fund capital gains taxes, you might want to start adjusting those portfolios to avoid a repeat.
The trick is knowing when and where to move in or out.
<i>Breakfast with Benjamin</i>: Turns out, rare trips to the U.S. by a Pope have not always been good for stocks.
Change in focus away from jobs and inflation could mean increase is off the table until global economies recover.
Fighting the temptation to try and time the market pays off in the long run.
